Status:
COMPLETED
A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Decompensated Cirrhosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This will be a randomized double blind study which will be conducted on patients admitted to Department of Hepatology from June 2013 to may 2014 at ILBS, New Delhi. Patients not having any exclusion c...
Eligibility Criteria
Inclusion
- Subjects aged 18-65 years
- All patients who are known to have cirrhosis of liver with portal hypertension and are compensated on presentation with no features of ascites/ jaundice/ bleed/ HE/ HRS.
- Only patients with alcoholic cirrhosis and cryptogenic cirrhosis (etiology work up negative) will be enrolled in the study.
Exclusion
- Sepsis ( Any culture positive: blood, urine, any other obvious source of infection: UTI, LRTI)
- Variceal bleed in the past 3 months
- Autoimmune disorders
- HCC (Hepatocellular Carcinoma)
- Multi organ failure
- Any features of decompensation in form of ascites/Jaundice/ HE (grade 3 or 4) / HRS
- HIV seropositivity
- Essential hypertension
- Pregnancy
- Refusal to participate in the study
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01902511
Start Date
July 1 2013
End Date
December 1 2015
Last Update
November 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver & Biliary Sciences
New Delhi, National Capital Territory of Delhi, India, 110070